Cost of Illness of Crohn's Disease

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.10, 2002-01, pp. : 639-652

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost of Illness and its Predictors for Parkinson's Disease in Germany

By Spottke Annika E.

PharmacoEconomics, Vol. 23, Iss. 8, 2005-01 ,pp. : 817-836

Adis International

Access to resources Recommend Favorite

Peripheral Arterial Obliterative Disease: Cost of Illness in France

By Montron A.

PharmacoEconomics, Vol. 13, Iss. 1 Part 2, 1998-01 ,pp. : 51-59

Adis International

Access to resources Recommend Favorite

Mercaptopurine more cost effective than mesalazine in Crohn's disease

Inpharma, Vol. 1, Iss. 1298, 2001-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Cost of Illness and Disease Severity in a Cohort of French Patients with Parkinson's Disease

By Le Pen C.

PharmacoEconomics, Vol. 16, Iss. 1, 1999-07 ,pp. : 59-69

Adis International

Access to resources Recommend Favorite

Cost Utility of Adalimumab versus Infliximab Maintenance Therapies in the United States for Moderately to Severely Active Crohn's Disease

By Yu Andrew P.

PharmacoEconomics, Vol. 27, Iss. 7, 2009-07 ,pp. : 609-621

Adis International

Access to resources Recommend Favorite